We are live on ! Find out more
OLVIG

Oliver Lagore Vanvalin Investment Group Portfolio holdings

AUM $255M
This Fund
S&P 500
This Quarter Est. Return
-2.5%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$253M
AUM Growth
-$20.7M
Cap. Flow
-$12.5M
Cap. Flow %
-4.94%
Top 10 Hldgs %
54.82%
Holding
911
New
137
Increased
183
Reduced
265
Closed
67
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VHT icon
301
Vanguard Health Care ETF
VHT
$19B
$28.7K 0.01%
122
-15
-11% -$3.66K
SCHP icon
302
Schwab US TIPS ETF
SCHP
$16.2B
$28.6K 0.01%
1,132
+1,098
+3,229% +$28.3K
BAUG icon
303
Innovator US Equity Buffer ETF August
BAUG
$204M
$28.6K 0.01%
865
AB icon
304
AllianceBernstein
AB
$3.4B
$28.4K 0.01%
937
-3
-0.3% -$95
NVS icon
305
Novartis
NVS
$290B
$28.3K 0.01%
278
+98
+54% +$9.95K
JBTM
306
JBT Marel
JBTM
$6.15B
$28K 0.01%
266
+16
+6% +$1.79K
CRSP icon
307
CRISPR Therapeutics
CRSP
$5.22B
$27.8K 0.01%
612
-203
-25% -$10.5K
AUGW icon
308
AllianzIM U.S. Equity Buffer20 Aug ETF
AUGW
$119M
$27.4K 0.01%
+1,129
New +$27.8K
SPH icon
309
Suburban Propane Partners
SPH
$1.18B
$27.3K 0.01%
1,703
+303
+22% +$4.48K
EVV
310
Eaton Vance Limited Duration Income Fund
EVV
$1.08B
$27.1K 0.01%
3,000
COIN icon
311
Coinbase
COIN
$39.3B
$26.7K 0.01%
355
-410
-54% -$34.6K
DFAI
312
Dimensional International Core Equity Market ETF
DFAI
$18B
$26.6K 0.01%
1,020
+71
+7% +$1.93K
C icon
313
Citigroup
C
$231B
$26.5K 0.01%
645
+43
+7% +$1.89K
HON icon
314
Honeywell
HON
$74.6B
$26.4K 0.01%
152
+11
+8% +$2.01K
DFAT icon
315
Dimensional US Targeted Value ETF
DFAT
$14.8B
$26K 0.01%
569
+32
+6% +$1.52K
DUHP icon
316
Dimensional US High Profitability ETF
DUHP
$12.7B
$26K 0.01%
1,012
+59
+6% +$1.58K
DPG
317
Duff & Phelps Utility and Infrastructure Fund
DPG
$527M
$25.9K 0.01%
3,000
URA icon
318
Global X Uranium ETF
URA
$6.31B
$25.8K 0.01%
953
-47
-5% -$1.1K
NEM icon
319
Newmont
NEM
$124B
$25.7K 0.01%
696
+196
+39% +$7.97K
NOW icon
320
ServiceNow
NOW
$129B
$25.7K 0.01%
230
+45
+24% +$5.13K
RIV
321
RiverNorth Opportunities Fund
RIV
$319M
$25.2K 0.01%
2,400
QYLD icon
322
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.28B
$25.2K 0.01%
1,500
+430
+40% +$7.55K
BBY icon
323
Best Buy
BBY
$17.5B
$25K 0.01%
360
TER icon
324
Teradyne
TER
$63B
$24.7K 0.01%
246
GSK icon
325
GSK
GSK
$101B
$24.2K 0.01%
667
+89
+15% +$3.16K

Similar funds

Oliver Lagore Vanvalin Investment Group's Q3 2023 Portfolio in Review

As of Q3 2023, Oliver Lagore Vanvalin Investment Group held 911 positions worth $253M, down 7.6% from $273M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Oliver Lagore Vanvalin Investment Group withdrew a net $12.5M in Q3 2023, closing 67 positions and reducing 265 holdings. Its most notable exit was iShares 10-20 Year Treasury Bond ETF, an estimated $177K position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.2% of assets, up from 3.9% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Oliver Lagore Vanvalin Investment Group opened a new position in BondBloxx Bloomberg Six Month Target Duration US Treasury ETF worth $3.55M.

  • Oliver Lagore Vanvalin Investment Group's largest Q3 2023 buy was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 70,585 shares worth $3.55M.
  • Oliver Lagore Vanvalin Investment Group added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q3 2023, an estimated $38M increase.
  • Oliver Lagore Vanvalin Investment Group's biggest Q3 2023 reduction was Invesco S&P 500 Low Volatility ETF, cutting an estimated $19.7M.
  • Oliver Lagore Vanvalin Investment Group fully exited iShares 10-20 Year Treasury Bond ETF in Q3 2023, selling an estimated $177K.
  • Oliver Lagore Vanvalin Investment Group's ten largest holdings make up 55% of its $253M portfolio in Q3 2023.
  • Oliver Lagore Vanvalin Investment Group opened 137 new positions and closed 67 in Q3 2023.
  • Oliver Lagore Vanvalin Investment Group's portfolio value fell 7.6% quarter-over-quarter to $253M.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q3 2023, filed 9 Nov 2023.